Literature DB >> 7822070

Immunological status of competitive cyclists before and after the training season.

Z Baj1, J Kantorski, E Majewska, K Zeman, L Pokoca, E Fornalczyk, H Tchórzewski, Z Sulowska, R Lewicki.   

Abstract

The total number of leucocytes, T lymphocyte subsets, mitogen induced proliferation of lymphocytes, Il-2 generation, adherence capacity and chemiluminescence of granulocytes were measured and a leukergy test performed in fifteen young cyclists. The investigations were carried out at rest at the beginning of a training season and after six months of intensive training and a racing season, cycling approximately 500 km a week. Baseline values of the tested immune parameters were within the range observed in 16 non-trained healthy controls except significantly increased non stimulated neutrophil chemiluminescence. The second cyclo-ergometer test in August showed a marked improvement in the performance capacity of the cyclists. Significant decrease in absolute numbers of CD3+ and CD4+ cells, diminished IL-2 generation and fMLP and PMA stimulated chemiluminescence of neutrophils were noted. Surprisingly, a marked increase in lymphocyte proliferation induced by PHA and anti-CD3 MoAb and normalisation in non stimulated neutrophil chemiluminescence were also observed at rest after the training season. We conclude that long-lasting intensive training may result in significant alterations in lymphocyte number and composition and in neutrophil oxidative burst capacity, but their actual significance for immunity is seen controversially.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822070     DOI: 10.1055/s-2007-1021067

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  20 in total

1.  Immune function in female elite rowers and non-athletes.

Authors:  D C Nieman; S L Nehlsen-Cannarella; O R Fagoaga; D A Henson; M Shannon; J M Hjertman; R L Schmitt; M R Bolton; M D Austin; B K Schilling; R Thorpe
Journal:  Br J Sports Med       Date:  2000-06       Impact factor: 13.800

2.  Effects of exercise and training on natural killer cell counts and cytolytic activity: a meta-analysis.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1999-09       Impact factor: 11.136

Review 3.  Effects of exercise on lymphocytes and cytokines.

Authors:  B K Pedersen; A D Toft
Journal:  Br J Sports Med       Date:  2000-08       Impact factor: 13.800

4.  Plasma cytokine changes in relation to exercise intensity and muscle damage.

Authors:  Jonathan M Peake; Katsuhiko Suzuki; Matthew Hordern; Gary Wilson; Kazunori Nosaka; Jeff S Coombes
Journal:  Eur J Appl Physiol       Date:  2005-09-06       Impact factor: 3.078

5.  Risk of upper respiratory tract infection in athletes: an epidemiologic and immunologic perspective.

Authors:  D C Nieman
Journal:  J Athl Train       Date:  1997-10       Impact factor: 2.860

Review 6.  Exercise and immune function. Recent developments.

Authors:  D C Nieman; B K Pedersen
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

7.  The effects of altered exercise distribution on lymphocyte subpopulations.

Authors:  C R Host; K I Norton; T S Olds; E L Lowe; S P Mulligan
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

8.  Effect of daily mixed nutritional supplementation on immune indices in soldiers undertaking an 8-week arduous training programme.

Authors:  Bethany C Diment; Matthew B Fortes; Julie P Greeves; Anna Casey; Ricardo J S Costa; Robert Walters; Neil P Walsh
Journal:  Eur J Appl Physiol       Date:  2011-08-06       Impact factor: 3.078

9.  Effects of moderate endurance exercise and training on in vitro lymphocyte proliferation, interleukin-2 (IL-2) production, and IL-2 receptor expression.

Authors:  S G Rhind; P N Shek; S Shinkai; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 10.  Physiological changes associated with the pre-event taper in athletes.

Authors:  Iñigo Mujika; Sabino Padilla; David Pyne; Thierry Busso
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.